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Abstract
Structural analyses of heterologously expressed mammalian membrane proteins remain a great challenge given that
microgram to milligram amounts of correctly folded and highly purified proteins are required. Here, we present a novel
method for the expression and affinity purification of recombinant mammalian and in particular human transport proteins
in Xenopus laevis frog oocytes. The method was validated for four human and one murine transporter. Negative stain
transmission electron microscopy (TEM) and single particle analysis (SPA) of two of these transporters, i.e., the potassium-
chloride cotransporter 4 (KCC4) and the aquaporin-1 (AQP1) water channel, revealed the expected quaternary structures
within homogeneous preparations, and thus correct protein folding and assembly. This is the first time a cation-chloride
cotransporter (SLC12) family member is isolated, and its shape, dimensions, low-resolution structure and oligomeric state
determined by TEM, i.e., by a direct method. Finally, we were able to grow 2D crystals of human AQP1. The ability of AQP1
to crystallize was a strong indicator for the structural integrity of the purified recombinant protein. This approach will open
the way for the structure determination of many human membrane transporters taking full advantage of the Xenopus laevis
oocyte expression system that generally yields robust functional expression.
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Introduction
The number of membrane proteins for which high-resolution
3D structures have been published is still low, amounting to 293
unique structures as of June 2011 (http://blanco.biomol.uci.edu/
Membrane_Proteins_xtal.html) in contrast to over ten thousand
structures of water-soluble proteins. Among these unique struc-
tures, most are of bacterial membrane proteins expressed in
bacteria or of eukaryotic membrane proteins expressed at
unusually high levels in their natural environment. Otherwise,
only ,20 eukaryotic structures are of recombinant membrane
proteins [1].
The major bottleneck for structural studies of mammalian
membrane proteins is the production of micrograms to milligrams
of highly purified and correctly folded protein implying that
heterologous overexpression will very often be mandatory. For
high-resolution structure determination by electron and X-ray
crystallography, milligram amounts of protein are required to
grow well-diffracting 2D and 3D protein crystals. On the other
hand, for low- (10–30 A˚) and medium-resolution (,10 A˚)
structure determination by negative stain and TEM of single
particles or of moderately ordered 2D crystals, microgram
amounts of protein are generally sufficient. Such low- and
medium-resolution structures are nonetheless informative given
that they reveal the arrangement of transmembrane alpha-helices
and other secondary structure elements within membrane proteins
as well as their supramolecular assembly.
Expression systems currently used to produce membrane
proteins for structural studies include bacteria, yeast, insect cells,
cell-free approaches and mammalian cells. Each system has its
advantages but none is optimal for all types of membrane proteins.
The Xenopus laevis oocyte expression system could represent one
exception given that it has been shown to allow for the robust
expression of many functional mammalian channels and solute
carriers (SLCs) [2]. This system owes its success to its ability to
translate heterologous mRNA and cDNA-derived cRNA efficient-
ly, and to provide most of the necessary cofactors required for the
functional expression of recombinant proteins at the cell surface.
Due to technical and methodological limitations, however, there
have been no reports describing the purification of recombinant
mammalian membrane proteins from oocytes, e.g. for structural
studies.
In the current study, X. laevis oocytes were used to express
recombinant mammalian (in particular human) transport proteins
for their subsequent purification and structural characterization.
Channels and SLCs were taken as model proteins because they
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represent the majority of transport proteins, are linked to
numerous inherited and acquired human diseases and correspond
to key therapeutic targets. Purification was achieved by expressing
recombinant proteins tagged with multiple epitopes and by using a
novel procedure for the preparation of egg yolk-depleted total
membranes. These two features were crucial for the successful
purification of transport proteins.
Five transport systems were purified in microgram amounts
using the novel method: aquaporin-1 (AQP1), glutamate trans-
porter 1 (EAAC1 or SLC1A1), peptide transporter 1 (PEPT1 or
SLC15A1) and sodium-glucose-cotransporter 1 (SGLT1 or
SLC5A1) from human, and potassium-chloride cotransporter 4
(KCC4 or SLC12A7) from mouse. To validate our approach, we
first tested the expression, localization and function of recombi-
nant AQP1 and KCC4 in oocytes. Negative stain TEM and SPA
of purified AQP1 and KCC4 indicated homogenous particle
distributions and the expected oligomeric states. From the
purification procedure described here, lastly, it was possible to
grow 2D crystals of human AQP1 expressed in Xenopus laevis
oocytes, paving the way for future structural analyses of
mammalian membrane proteins by crystallography techniques.
Results
Design of the expression vector and workflow
The oocyte expression vector Pol1 [3] was modified by adding
the decahistidine (10x-His), FLAG and hemagglutinin (HA)
epitope tags in front of the multiple cloning site (Figure 1A). A
cleavage site for the human rhinovirus 3C (HRV3C) protease (also
known as PreScissionTM) was inserted between the FLAG and HA
tags to remove the His and FLAG tags from purified proteins.
Importantly, each of the epitope and proteolytic cleavage modules
was flanked by convenient restriction sites to allow for their
eventual removal or replacement by other modules. Lastly, the
multiple cloning site was redesigned to add a XhoI site and to
ensure in-frame reading through all of the added sequences and
the transporter-encoding insert.
The method used to isolate recombinant transport proteins
from Xenopus laevis oocytes is described in the flow diagram of
Figure 1B. Briefly, oocytes were extracted from frogs and
individualized (day 1), injected with cDNA-derived cRNA
encoding for the corresponding recombinant transporter (day 2),
incubated at 18uC during days 3 and 4 (when proteins are
expressed at their highest levels) and used in various studies
thereafter (see below). Isolation of total membranes, membrane
solubilization with detergent and affinity chromatography was
done on day 5. After overnight protease cleavage at 4uC, transport
proteins were eluted (day 6) for further analyses.
Isolation of egg yolk-depleted total membranes of X.
laevis oocytes
Egg yolk proteins such as vitellogenins [4] are abundant and
sticky molecules hindering drastically detergent solubilization of
isolated membranes and protein binding to chromatography
resins. Removal of the egg yolk from homogenates was a difficult
and challenging step towards the purification of recombinant
transport proteins. It was successfully achieved by using the
following approach: i.) lysis of the oocytes in a salt-free 20 mM
Figure 1. Schematic representation of the expression vector pMJB08, and the workflow for the expression in X. laevis oocytes and
purification of mammalian transport proteins. (A) Three tags, i.e. 10x-His, FLAG and HA, and one proteolytic site for the HRV3C protease were
translated in-frame at the N-terminus of our transport proteins. The HRV3C protease cleaves between the amino acids QG (in red). The vector is setup
in a modular manner: i.) the FLAG tag (yellow) can be swapped by a different tag X (e.g. c-myc, HA, etc.) using the unique restriction sites SalI and
NotI; ii.) the HRV3C protease cleavage site (green) can be replaced by a different proteolytic site Y (e.g. for TEV protease, thrombin, etc.) using the
unique restriction sites NotI and NcoI; iii.) the HA tag (red) can be exchanged by a different tag Z (e.g. c-myc, FLAG, etc.) using the unique restriction
sites NcoI and all enzymes in the multi cloning site (MCS) except XmaI; iv.) a XmaI digestion removes all tags and epitopes to obtain the original Pol1
vector. (B) Schematic representation of the workflow for the expression and purification of transport proteins in X. laevis oocytes. See Methods section
for a detailed description of the different steps.
doi:10.1371/journal.pone.0021901.g001
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Tris-HCl (pH 8; Tris) buffer, ii.) differential centrifugation to
obtain total membranes and iii.) membrane wash in a high-salt
(1 M NaCl) Tris buffer. In Figure S1 the effects of these buffers as
well as those of other buffers for oocyte lysis and membrane
isolation are illustrated. As seen in Figure S1A, lysis of oocytes in
high ionic strength Tris buffers, i.e., Tris with 1 M NaCl (NaCl)
and Tris with 100 mM MgCl2 (MgCl2), leads to solubilization of
egg yolk proteins, while lysis in salt-free Tris buffers, i.e., Tris with
5 mM EDTA/EGTA (EDTA/EGTA) and Tris only (Tris), does
not. The almost complete solubilization of the egg yolk proteins at
high ionic strength is clearly seen by the black pellets (color of egg
pigments) after low spin centrifugation at 1,000 g of the oocyte
homogenates (Figure S1A, NaCl and MgCl2). In contrast, yellow
pellets are found in the EDTA/EGTA and Tris lyses, indicating
minor solubilization of the egg yolk proteins. The supernatants
collected after the 1,000 g centrifugation of the four oocyte lysates
(NaCl, MgCl2, EDTA/EGTA and Tris) were ultracentrifuged at
150,000 g and the total membranes obtained (pellets). SDS-PAGE
from the supernatants and pellets after ultracentrifugation is shown
in Figure S1B. In agreement with the results displayed in Figure
S1A, large amounts of egg yolk proteins, e.g. vitellogenins that
migrate at ,100 kDa [4], were found in supernatants and pellets
from high ionic strength lyses (see NaCl and MgCl2), and low
amounts in those from salt-free lyses (see EDTA/EGTA and Tris).
Total membranes from oocyte lysis in Tris buffer contained
the smallest amounts of egg yolk contamination (Figure S1B,
rightmost lane). Importantly, this contamination was almost
completely removed from the preparations through a subsequent
wash step of the total membranes in Tris buffer containing 1 M
NaCl (Figure S1C, rightmost lane).
Expression, localization and function of recombinant
AQP1 and KCC4 in X. laevis oocytes
AQP1 and KCC4 were chosen as model channel and SLC type
proteins, respectively, for the study of the structure of purified
recombinant transporters expressed in Xenopus laevis oocytes. As a
first step, we investigated their expression, localization and
function in oocytes.
Cell surface biotinylation experiments with multi-AQP1 and
multi-KCC4 (that is of AQP1 and KCC4 with a long N-terminal
extension as described in Figure 1A) expressing oocytes were
performed. Subsequent Western blot analyses revealed their
expression in the plasma membrane (Figure 2A). Confocal
immunofluorescence was consistent with the cell surface localiza-
tion of those recombinant proteins (Figure 2B).
Figure 2. Expression, localization and function of recombinant
AQP1 and KCC4 in X. laevis oocytes. (A) Cell surface biotinylation
experiments and subsequent Western blot analyses using anti-HA
antibodies indicated plasma membrane expression of multi-AQP1 and
multi-KCC4 (i.e. AQP1 and KCC4 containing a long N-terminal extension
as described in Figure 1A): see multi-AQP1 monomer band below the
37 kDa marker, and multi-KCC4 monomer and dimer bands below the
150 kDa and above the 250 kDa markers, respectively. (B) Confocal
immunofluorescence microscopy using anti-HA antibodies localized
multi-AQP1 and multi-KCC4 in the plasma membrane. These represen-
tative images were recorded at 10x magnification. Scale bar: 200 mm.
(C) Functional characterization of different AQP1 constructs. Swelling in
water of non-injected oocytes (Control) and oocytes injected with cRNA
of wt-AQP1 (no N-terminal extension), HA-AQP1 (only N-terminal HA
epitope) and multi-AQP1. Multi-AQP1 was not functional while wt-AQP1
and HA-AQP1 had comparable activities. Data correspond to oocyte
volume variation measurements in water at different time points. They
are shown as averages (6 S.E.) of 4-6 experiments. (D) Functional
characterization of different KCC4 constructs. Similar levels of Rb+ influx
into wt-KCC4 and multi-KCC4 expressing oocytes indicated full activity
of the recombinant transporter. Data correspond to Rb+ influxes and
are shown as averages (6 S.E.) of 4 experiments (9-15 oocytes/
experiment). Oocytes were non-injected (Controls), or injected with
20 ng of AQP1 and KCC4 cRNAs for expression and localization studies
(A and B), and injected with 5 ng of AQP1 and 20 ng of KCC4 cRNAs for
functional studies (C and D).
doi:10.1371/journal.pone.0021901.g002
Recombinant Human Transporters from Frog Oocytes
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21901
The functional characterization of AQP1 was carried out by
measuring cell volume variations during osmotic swelling in water
and that of KCC4 by measuring Rb+ influx. Based on these
studies, multi-AQP1 was non-functional, the increase in cell
volume being similar to that of control oocytes and well below that
seen in oocytes expressing untagged and HA-tagged AQP1 (wt-
AQP1 and HA-AQP1; Figure 2C). Although these results indicate
that the N-terminal extension before the HA epitope abolishes
function, it should be noted that the functional HA-AQP1 protein
is similar to the truncated multi-AQP1 protein obtained after
purification for which the structural organization is not disrupted
(as will be shown below). On the other hand, levels of Rb+ influx
by multi-KCC4 expressing oocytes were similar to those observed
for wt-KCC4 expressing oocytes indicating full activity of the
recombinant transporter (Figure 2D).
Purification of recombinant aquaporin-1 and SLC
transporters expressed in X. laevis oocytes
Egg-yolk depleted total membranes were solubilized with the
non-ionic and mild detergent Triton X-100. After removal of the
non-solubilized fraction by ultracentrifugation, His-tagged pro-
teins in the supernatant were bound to a cobalt resin and washed
with imidazole to diminish background contamination caused by
non-specific protein binding. Transporters were then specifically
eluted from the cobalt resin by HRV3C protease cleavage directly
onto the column instead of by the common elution by high
concentrations of imidazole. Because the HRV3C protease is His-
tagged, it remains bound to the cobalt resin not contaminating the
eluted transport proteins. As expected, purified recombinant
proteins had a shorter N-terminus (only HA epitope, see
Figure 1A) than the originally expressed forms, e.g. multi-AQP1.
Figure 3 illustrates the high level of purity achieved by this
method for AQP1, KCC4, EAAC1, PEPT1 and SGLT1. All of
the recombinant transporters (non- and/or glycosylated, and
oligomeric forms) were identified on silver-stained SDS/poly-
acrylamide gels (Figure 3A,D,F,H, and J) and their identity was
confirmed by Western blot analyses using anti-HA antibodies
(Figure 3B,E,G,I and K). Importantly, no contaminants or
protein degradation are found on silver-stained SDS/polyacryl-
amide gels and Western blots, thus validating the specific
purification procedure and indicating correct folding of the
proteins. Lastly, immunoblotting using anti-pentahistidine anti-
bodies suggested that the eluted recombinant transporters were
free of their His-tags and that His-tagged HRV3C protease did
not co-elute (see Figure 3C for AQP1 used as example). In case of
persisting protein contaminations, purity could be improved by a
second affinity chromatography step based on the FLAG epitope.
This purification step would be subsequent to the cobalt affinity
chromatography, but eluting the proteins with imidazole instead
of by protease cleavage onto the column. As documented in
Figure 3, the five tested transport proteins were highly pure,
therefore not needing an additional FLAG affinity chromatogra-
phy step.
Determination of the protein concentration after purification
allowed us to estimate the amount of protein expressed per oocyte.
Expression levels for our model proteins AQP1 and KCC4 were
,6 and ,3 ng per oocyte, respectively. The overall range for the
five tested transport proteins was 3–7 ng per oocyte.
Structural analyses by TEM of purified recombinant AQP1
and KCC4
Purified HA-AQP1 and HA-KCC4 were adsorbed on parlo-
dion carbon-coated grids, washed, negatively stained and
examined by TEM. In Figure 4A the homogeneity of the purified
HA-AQP1 can be appreciated. Numerous particles exhibit a
square shape (arrowheads) with a side length and diameter of
,70 A˚ and ,100 A˚, respectively. In these particles, a central
stain-filled pit and four major stain-excluding units are observed:
see gallery in Figure 4B for a selection of AQP1 top views. These
features are more pronounced in the average calculated from 270
top views of HA-AQP1 (Figure 4B, rightmost frame). The shape,
dimensions and structure are in agreement with those of native
human AQP1 tetramers purified from erythrocytes [5]. It should
be noted that also other slightly different shapes/projections (i.e.
not perfectly square) of AQP1 are seen in Figure 4A, because of
the several possible particle orientations upon adsorption on a not
perfectly flat support film.
On electron micrographs of purified HA-KCC4 (Figure 4C) two
populations of particles were found. Smaller particles (marked by
arrows to the left) were minor and slightly elliptical with an
approximate diameter of ,100 A˚ (,7,850 A˚2), while larger
particles (marked by arrows to the right) were major and
rectangular with dimensions of ,130 A˚ x ,100 A˚ (13,000 A˚2).
Based on the calculated surfaces, the larger particles were twice as
big as the smaller particles suggesting two oligomeric forms of
KCC4.
2D crystallization of AQP1 and analysis of tubular crystals
For 2D crystallization, the detergent Triton X-100 was
exchanged by n-decyl-beta-D-maltopyranoside (DM) during
protein concentration (see Methods). Because the critical micellar
concentration of DM is about 6 times higher than that of Triton
X-100, DM is more suitable for fast removal of detergent by
dialysis and thus for 2D crystallization.
The Coomassie Blue-stained SDS/polyacrylamide gel in Figure 5A
shows the high purity of the HA-AQP1 protein used for 2D
crystallization. Nonglycosylated HA-AQP1 migrates at ,25 kDa
while glycosylated forms above (compare with Figure 3A and B).
Tubular crystals of HA-AQP1 were successfully grown (Figure 5B)
using reconstitution conditions similar to those previously reported for
2D crystals of human AQP1 from erythrocytes [6]. Power spectra
calculated from flattened HA-AQP1 tubes (Figure 5C) showed strong
diffraction spots at, (49 A˚)21 (indicated by a circle) and weaker ones
at , (44 A˚)21 (indicated by arrowheads). Diffraction of our tubular
crystals also indicated mosaicity and anisotropy impeding the
determination of the crystal lattice parameters and the calculation
of a projection structure.
Discussion
The structure determination of membrane proteins is lagging
behind that of water-soluble proteins mainly due to the difficulty in
heterologously expressing and isolating the required amounts for
structural analyses. Although advances have been achieved over
the past years (mainly with prokaryotic membrane proteins), the
number of structures of eukaryotic and in particular mammalian
polytopic membrane proteins is still negligible. In the various cell
types and systems that are currently used to express mammalian
membrane proteins, i.e., bacteria, yeast, insect cells, mammalian
cell lines and cell-free systems, proteins are often non-functional,
mistargeted, misfolded, aggregated or degraded at abnormal rates.
Yet, eukaryotic cell expression systems have been shown to be
more appropriate than prokaryotic and cell-free systems to
generate functional animal proteins because of their specific lipid
environment and more elaborated translational and post-transla-
tional machineries.
Recombinant Human Transporters from Frog Oocytes
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X. laevis oocytes are being used very successfully for expression
cloning [7,8] and to study the function of eukaryotic membrane
proteins, especially of mammalian transporters [2]. The main
advantage of oocytes compared to other cell types is their ability to
translate a wide variety of heterologous mRNAs or cDNA-derived
cRNAs efficiently and to modify translation products into functional
membrane proteins [9]. On the other hand, obtaining significant
amounts of purified membrane proteins from this expression system
has always been considered a great challenge given that the presence of
egg yolk limits or even impedes protein purification.
In this study, we made use of the advantages offered by the X.
laevis oocyte expression system and established for the first time a
method that allows isolating highly pure recombinant mammalian
transport proteins. For this novel method, we engineered an
expression vector (called pMJB08) provided with all of the
necessary features for affinity purification and immunodetection
of membrane proteins as well as for the partial removal of the
epitope tags introduced (see Results and Figure 1A). A challenging
but crucial step in the purification procedure was to remove the
contaminating egg yolk from membrane preparations. This was
achieved by lysing oocytes in a salt-free buffer, separating cell
fractions by differential centrifugation and washing total mem-
branes with a high-salt buffer (see Results and Figure S1). Through
this method, five different transport systems (AQP1, KCC4,
EAAC1, PEPT1, and SGLT1) were produced in microgram
amounts with no contamination or degradation detectable on
silver-stained SDS/polyacylamide gels and by Western blot
analyses (Figure 3). The absence of degradation indicated correct
folding of the transporters and thus no exposure of unfolded
protein domains to proteases. Further studies showed that the two
model proteins (AQP1 and KCC4) produced with pMJB08 were
expressed and localized at the plasma membrane and that multi-
KCC4 was fully functional (Figure 2). Although multi-AQP1 was
devoid of functional activity, HA-AQP1 did behave as a wild-type
Figure 3. SDS-PAGE, silver-staining and Western blot analyses of purified, recombinant channel and SLC transporters expressed in
X. laevis oocytes. Silver-stained SDS/polyacrylamide gels (A,D,F,H and J), and Western blots (using anti-HA: B,E,G,I and K and anti-pentahistidine
antibodies: C) from representative purifications. (A) and (B) The recombinant, nonglycosylated human AQP1 monomer runs at ,25 kDa similar to
native AQP1 isolated from human erythrocytes [6]. Additional higher molecular mass bands are discerned corresponding to glycosylated and dimeric
AQP1 forms. (C) No His-tagged proteins were immunodetected in purified AQP1 preparations by immunoblotting (lane: AQP1). In contrast, strong
signals were obtained for the His-tagged protein markers (lane: M; positive control). (D) and (E) Monomer (below 150 kDa marker) and dimer
(,250 kDa) bands of non- and glycosylated, recombinant mouse KCC4 [12,13]. (F) and (G) Monomeric (,75 kDa [16]), dimeric (,150 kDa) and
oligomeric glycosylated, recombinant human EAAC1. (H) and (I) Monomeric (,70 kDa [17]), dimeric (,140 kDa) and oligomeric non- and
glycosylated, recombinant human PEPT1. (J) and (K) Monomeric non- (,55 kDa [18]) and glycosylated (,70 kDa), and oligomeric non- and
glycosylated, recombinant human SGLT1. All bands on silver-stained SDS/polyacrylamide gels can be assigned to bands observed on corresponding
Western blots.
doi:10.1371/journal.pone.0021901.g003
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water channel, suggesting that removal of the His-FLAG epitope
by the HRV3C protease during purification leads to the formation
of an active transport system.
Negative stain TEM and SPA showed highly homogeneous
preparations of purified HA-AQP1 in the expected tetrameric
form (Figure 4A and B), implying correct protein folding and
supramolecular assembly. On the other hand, KCC4 preparations
were almost homogeneous, including a major population of larger
particles and a minor one of smaller particles (Figure 4C–E). The
larger particles were at a size that is consistent with those of
homodimers, which are one of the assembly forms taken by all
KCC family members as suggested recently by biochemical
experiments [10]. The other particles were half as big but
exhibited a similar appearance, pointing to a monomer-dimer
equilibrium or a partial disruption of the larger particles (dimers)
into smaller particles (monomers) during detergent solubilization.
It should be noted that this is the first time that a member of the
cation-chloride cotransporter (SLC12) family is purified, and that
its shape, dimensions, low-resolution structure and oligomeric state
is determined by TEM (i.e. by a direct method).
For TEM and SPA, relatively low concentrations of protein are
needed, e.g., 2–3 ml per grid of a 30–60 mg/ml protein solution
depending on the molecular mass of the protein/complex being
analyzed and the desired particle distribution density on the grid.
This implies that the method presented here is highly attractive for
structural studies of recombinant membrane proteins and their
complexes by TEM and SPA. To set up 2D crystallization trials,
,50 mg of pure HA-AQP1 was prepared from ,7800 oocytes
(Figure 5A). Tubular AQP1 crystals were successfully grown
(Figure 5B), and indicated strong and weaker diffraction spots at
,(49 A˚)21 and ,(44 A˚)21, respectively (Figure 5C). These
frequencies may be assigned to diffraction spots (62,0) or (0,62)
at (48 A˚)21, and (62,61) or (61,62) at,(43 A˚)21 of a negatively
stained human AQP1 2D crystal with typical lattice parameters of
a = b = 96 A˚, gamma = 90u and p4221 symmetry [5]. Importantly,
the ability of HA-AQP1 to crystallize is a strong indicator of the
structural integrity of the purified recombinant protein.
Currently, we are able to isolate microgram amounts of pure
transport protein from manually injected oocytes for TEM, SPA
and 2D crystallization. The yield is relatively low compared to other
expression systems, but the protein produced is of excellent quality,
i.e. homogeneous, correctly folded/assembled, and neither prone to
degradation nor aggregation. In the future, automated injection of
several thousands oocytes per hour by commercial robots, now up
to 600 by Roboinject (Multi channel Systems, Germany) [11], will
allow purification of enough mammalian recombinant transport
proteins to grow 3D crystals for structure determination by X-ray
crystallography. To us, this prediction is realistic considering that it
is now possible to carry out 3D crystallization trials with 250–750 ng
of protein per conditions, e.g. in 50 nl drops.
Materials and Methods
All animal experiments were in accordance with the Swiss
Animal Welfare Law and were approved by the Local Veterinary
Authority Bern (Veterina¨ramt Bern; Permit Number: 110/08).
Expression vector
For the heterologous expression of transporters in X. laevis
oocytes and their subsequent affinity purification and immunode-
tection, we modified the Pol1 expression vector [3] by adding an
N-terminal extension as described in Results and Figure 1A. This
new vector named pMJB08 was generated by the insertion of two
prehybridized complementary oligonucleotide fragments, which
possess single-stranded cohesive, and XmaI-NcoI- and NcoI-
HindIII-compatible ends, into a XmaI-HindIII-treated Pol1
vector fragment. The two upper oligonucleotides and their
complementary oligonucleotides are found in Table S1. Fragments
were ligated with the Rapid DNA Ligation Kit (Roche) and the
vector was propagated in XL1-Blue Cells (Stratagene).
cDNA constructs
cDNAs from KCC4 (mouse), and AQP1, EAAC1, PEPT1 and
SGLT1 (human) were cloned by PCR (using Pfu Turbo DNA
Polymerase, Stratagene) from carrier cDNA constructs of our
laboratory. The oligonucleotides used for PCR reactions are found
in Table S1. All digested cDNAs were introduced in-frame into
the pMJB08 expression vector.
Protein expression in X. laevis oocytes
Ovarian tissue was surgically removed from the frogs and
treated with 3 mg/ml of collagenase A (Roche) for 2 h in Modified
Figure 4. Negative stain TEM of purified recombinant AQP1 and KCC4. The homogeneity of the purified HA-AQP1 protein is reflected in the
electron micrograph. Numerous particles exhibit a square shape (arrowheads), which is typical for AQP1 top views [5]. The gallery in (B) displays well-
preserved top views of HA-AQP1. The last particle in this gallery (rightmost) is an average calculated from 270 top views. No four-fold symmetry was
imposed. In the raw images and average, four densities are clearly visible. The average was low-pass filtered to 15 A˚ resolution. (C) Overview
micrograph of purified HA-KCC4. Two populations of particles are distinct: smaller (minority; arrows to the left) and larger particles (majority; arrows
to the right). The former and latter particles were magnified and are displayed in (D) and (E), respectively. The scale bars represent 500 A˚ (A and C).
The frame sizes of the magnified particles are 138 A˚ (B) and 204 A˚ (D and E).
doi:10.1371/journal.pone.0021901.g004
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Barth’s Medium (MBM: 88 mM NaCl, 1 mM KCl, 2.4 mM
NaHCO3, 0.82 mM MgSO4, 0.66 mM NaNO3, 0.75 mM CaCl2,
10 mM HEPES-NaOH (pH 7.4)) but without CaCl2 and
supplemented with P/S antibiotics (GIBCOTM Penicillin-Stepto-
mycin liquid, Invitrogen). This buffer is isoosmolar relative to the
X. laevis plasma (,200 mOsm). Subsequently, defolliculated stage
V-VI oocytes were isolated, transferred into plates containing
MBM medium supplemented with P/S antibiotics and maintained
at 18uC prior to injection. Depending on the experiment, oocytes
were injected with 5 or 20 ng of cDNA-derived cRNA (in-vitro
transcription with the mMESSAGE mMACHINEH T7 kit,
Ambion) and maintained for 3–4 days at 18uC in MBM
supplemented with P/S antibiotics.
Isolation of egg yolk-depleted total membranes from
oocytes
Between 350–400 oocytes were homogenized in 9 ml of 20 mM
Tris-HCl (pH 8) supplemented with the CompleteH protease
inhibitor cocktail (Roche). To remove cell debris, nuclei and
pigments, the homogenate was subjected to a low spin centrifuga-
tion (1,000 g; 15 min; 4 uC). The supernatant was harvested with a
glass Pasteur pipette, transferred into an ultracentrifuge tube and
subjected to ultracentrifugation at 150,000 g (1 h; 4 uC). The pellet
containing total membranes was homogenized in 9 ml of high ionic
strength buffer (20 mM Tris-HCl (pH 8), 1 M NaCl) supplemented
with CompleteH and ultracentrifuged at 150,000 g (1 h; 4 uC).
Protein purification
The pellet of egg yolk-depleted total membranes from the
precedent ultracentrifugation was homogenized/solubilized in
9 ml of solubilization buffer: 20 mM Tris-HCl (pH 8), 150 mM
NaCl, 0.01% NaN3 and 2% Triton X-100 supplemented with
CompleteH and incubated on a rotator (1 h; 4uC). The non-
solubilized fraction was removed by ultracentrifugation at
150,000 g (1 h; 4 uC). The supernatant containing the detergent-
solubilized His-tagged transport protein was incubated with pre-
equilibrated HisPurTM cobalt resin (250 ml bed volume; Thermo
Scientific) on a rotator (3 h; 4 uC; binding step) and subsequently
transferred into a spin column (Promega). His-tagged proteins
bound to cobalt resin were washed thoroughly in three steps: i.)
20 ml of washing buffer: 20 mM Tris-HCl (pH 8), 150 mM NaCl,
0.01% NaN3, 0.05% Triton X-100 and 10 mM imidazole; ii.)
20 ml of washing buffer with 20 mM instead of 10 mM imidazole;
and iii.) 10 ml of cleavage buffer: 20 mM Tris-HCl (pH 8),
150 mM NaCl, 0.025% Triton X-100. The column was allowed
to drip and empty without letting the resin run dry. The tip of the
spin column was then cut and 300 ml of cleavage buffer containing
20 units of HRV3C (BioVision) were added. After sealing with
Parafilm M, the tip was mounted on a rotator and agitated to favor
proteolytic cleavage (overnight; 4 uC). Truncated, HA-tagged
proteins were eluted by a low spin centrifugation at 960 g (3 min;
4uC). Four to six purifications (i.e. one corresponds to protein
purified from 350–400 oocytes) were pooled in an AmiconH Ultra
100 K concentrator (Millipore) and concentrated to a final volume
of ,100 ml. The protein concentration was determined using the
BCATM protein assay kit (Pierce, Perbio Science).
SDS-PAGE and Western blot analyses
Purified proteins were boiled in 5x sample buffer (without reducing
agent) and run on 6% Tris-Tricine SDS/polyacrylamide gels. Gels
were either stained (silver or Coomassie Blue) or transferred onto
Immobilon-P membrane blots (Millipore) for Western blot analysis.
Blots were sequentially incubated with primary and secondary
antibodies. The primary antibodies, mouse monoclonal anti-HA
(Sigma) and anti-Penta-Histidine (Qiagen), were used at a dilution of
1/1,000. The secondary antibody, HRP-conjugated goat anti-mouse
anti-IgG (Bio-Rad), was used at a dilution of 1/4,000.
Cell surface biotinylation
For each experiment, twenty intact oocytes were incubated (1 h;
4uC) with 1.5 mg/ml sulfo-LC-NHS-(+)-Biotin (Pierce), washed
Figure 5. Tubular crystals of recombinant human AQP1. (A)
Coomassie Blue-stained SDS/polyacrylamide gel of the purified HA-
AQP1 used for 2D crystallization. Nonglycosylated HA-AQP1 migrates at
,25 kDa while glycosylated proteins migrate above. (B) Negatively
stained tubular crystals of HA-AQP1. The area marked by the white box
was magnified and is displayed as inset: tubular crystals with a typical
width of ,0.11 mm are seen. (C) The power spectrum calculated from a
flattened tubular HA-AQP1 crystal indicates regular order. Strong and
weaker diffraction spots are marked by a circle and arrowheads,
respectively. The scale bars represent 0.5 mm (B) and (50 A˚)21 (C). The
frame size of the inset in (B) is 0.50360.362 mm.
doi:10.1371/journal.pone.0021901.g005
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with quenching solution (100 mM glycine) and lysed in 1 ml of
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100,
0.5% Na-deoxycholate, 0.1% SDS supplemented with CompleteH.
After incubation (2 h; 4uC) and centrifugation at 18,000 g (15 min;
4 uC), supernatants were transferred into new tubes. Cell surface
biotinylated-proteins were purified by addition of 50 ml of
streptavidin agarose beads (Pierce), overnight incubation at 4uC,
and recovery of the beads by centrifugation at 9,000 g (1 min;
4 uC). Finally, proteins were released from the beads by boiling in
2x sample buffer, and subjected to SDS-PAGE and Western
analyses as described previously.
Immunofluorescence studies
Oocytes were fixed with 4% paraformaldehyde for 20 min and
permeabilized with 0.3% Triton X-100 for 5 min at room
temperature. After 1 h incubation in blocking solution (PBS with
5% goat serum, 0.5% bovine serum albumin, and 0.02% NaN3),
oocytes were incubated for another hour with rabbit polyclonal
anti-HA antibodies (dilution 1/200; Sigma) and for an additional
hour with Alexa FluorH 594-conjugated goat anti-rabbit anti-IgG
antibodies (dilution 1/4,000; Invitrogen). Images were recorded
with a C1 confocal laser microscope system (Nikon).
Cell volume measurements
Oocytes expressing wt-AQP1, HA-AQP1 and multi-AQP1
were incubated in water and volume variations were measured
during osmotic swelling with a SZ61 stereomicroscope (Olympus)
equipped with a DP20 digital camera (Olympus). Cell volumes
were calculated from cell radii measured at different time points.
Volumes in nanoliters (nl) were calculated from radii (r) measured
in mm, with the formula (4/36 p6 (r/10)3)6 106.
Influx studies
The function of wt-KCC4 and multi-KCC4 expressing oocytes
was determined as previously described [12,13]. Briefly, oocytes
were incubated for 1 h in a low Cl2/hypotonic solution (,5 mM
Cl2 and 125 mOsm) to activate KCC4, incubated for another
45 min in a physiological solution (86 mM Cl2 and ,200 mOsm)
supplemented with 5 mM Rb+ (used as a tracer of K+) and 10 mM
ouabain, and bathed several times in a wash solution supplement-
ed with 10 mM ouabain, 250 mM bumetanide and 250 mM
furosemide. Cells were then lysed in pure nitric acid and their Rb+
content was measured by atomic absorption spectrometry. The
data obtained were converted to fluxes (nmol/oocyte/h). All steps
were carried out at room temperature.
2D crystallization of AQP1
Eluates from twenty-one purifications (,7,800 oocytes, about 4
weeks of work) were pooled and concentrated to a final volume of
,100 ml. The detergent Triton X-100 was exchanged for DM in
the concentrator by addition of 400 ml of 20 mM Tris-HCl (pH 8),
150 mM NaCl, 0.15% DM to the ,100 ml of concentrated
protein, and concentrating back to a volume of ,100 ml. This was
repeated ten times to ensure complete exchange. The final volume
of ,100 ml had a protein concentration of ,0.5 mg/ml. For 2D
crystallization, purified HA-AQP1, i.e. truncated multi-AQP1,
was mixed with Escherichia coli polar lipids solubilized in 1% DM,
20 mM Tris-HCl (pH 8), 150 mM NaCl, 0.01% NaN3 at lipid-to-
protein ratio of 0.5, 0.75 and 1. 2D crystallization of HA-AQP1
was performed by dialysis of the protein/lipid/detergent mixture
at 24 uC for 14 days. The detergent-free dialysis buffer was 20 mM
Mes-NaOH (pH 6), 200 mM NaCl, 10 mM MgCl2, 2 mM DTT,
10% glycerol, 0.01% NaN3 as previously described for the 2D
crystallization of human AQP1 isolated from red blood cells [6].
Transmission electron microscopy
Detergent-solubilized transport proteins were adsorbed for
,10 s to parlodion carbon-coated copper grids rendered
hydrophilic by glow discharge at low pressure in air. Grids were
washed with three drops of double distilled water and stained with
2 drops of 0.75% uranyl formate. Grids of 2D AQP1 crystals were
prepared similarly but included a longer adsorption time of ,60 s.
Electron micrographs were recorded with a Philips CM12 TEM
operated at 80 kV and equipped with a Morada 11 megapixel
CCD camera.
SPA and image processing
SPA of purified HA-AQP1 and the calculation of the top view
in Figure 4B (rightmost panel) was performed using the EMAN
software package [14]. The power spectrum in Figure 5C of a
flattened tubular HA-AQP1 crystal was calculated using the
SEMPER system [15].
Supporting Information
Figure S1 Isolation of egg yolk-depleted total mem-
branes of X. laevis oocytes. (A) Homogenization of oocytes in
four different lysis buffers: i.) 20 mM Tris-HCl (pH 8; Tris) with
1 M NaCl (NaCl); ii.) Tris with 100 mM MgCl2 (MgCl2); iii.) Tris
with 5 mM EDTA/EGTA (EDTA/EGTA) and iv.) Tris only.
The pellets after low spin centrifugation at 1,000 g of the
homogenates are displayed. Buffers with high ionic strengths
(NaCl and MgCl2) solubilized egg yolk proteins, resulting in black
pellets mainly containing egg pigments. Salt-free buffers (EDTA/
EGTA and Tris) yielded yellow pellets characteristic of the egg
yolk. The four supernatants were collected and ultracentrifuged at
150,000 g (150 kg). (B) SDS-PAGE of the supernatants (S) and
pellets (P) after ultracentrifugation. Consistent with the results in
(A), supernatants and pellets from lyses at high ionic strength
contained large amounts of egg yolk contaminants, e.g. vitello-
genins migrating at ,100 kDa. In contrast, vitellogenins were
absent and weakly present in supernatants and pellets from
homogenates prepared in salt-free buffers. The best result was
obtained with Tris buffer: see rightmost lane. (C) The weak
vitellogenin contamination in the pellet (see lane between blue
lines in (C) and lane P 150 kg Tris in (B)) was almost completely
removed by the addition of a NaCl wash step. The beneficial effect
of this wash step for the purity of total membranes can directly be
compared with that of a wash with Tris buffer (see lanes labeled
‘Wash’ in the panel). The rightmost lane illustrates the isolation of
total membranes under the best conditions. The lane between the
two blue lines is from the same gel but from a different well. All
gels were stained with Coomassie Blue.
(TIF)
Table S1 Synthetic oligonucleotides used to generate
the pMJB08 vector and for PCR reactions. All oligonucle-
otides are written 59 to 39 excepted for the two complementary
oligonucleotides that are written 39 to 59. Bold letters designate
cohesive compatible enzyme restriction sites or enzyme restriction
sites in PCR oligonucleotides. S = sense, AS = anti-sense.
(DOC)
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